Itau Unibanco Holding S.A.’s Pacific Biosciences PACB Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-898	Closed	-$8.81K	–	295
2023 Q4	$8.81K	Sell	898 -218	-20%	-$1.78K	﹤0.01%	316
2023 Q3	$9.32K	Hold	1,116	–	–	﹤0.01%	428
2023 Q2	$14.8K	Buy	1,116 +2	+0.2%	+$24	﹤0.01%	440
2023 Q1	$12.9K	Hold	1,114	–	–	﹤0.01%	435
2022 Q4	$9.11K	Buy	+1,114	New	+$9.6K	﹤0.01%	461
2022 Q2	–	Sell	-1,113	Closed	-$10K	–	575
2022 Q1	$10K	Hold	1,113	–	–	﹤0.01%	432
2021 Q4	$23K	Buy	1,113 +257	+30%	+$6.2K	﹤0.01%	359
2021 Q3	$22K	Sell	856 -12	-1%	-$356	﹤0.01%	331
2021 Q2	$30K	Buy	+868	New	+$25.2K	﹤0.01%	264

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Itau Unibanco Holding S.A.'s PACB Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 898 shares — an estimated $8.81K sold.

Itau Unibanco Holding S.A. first reported a position in PACB in Q2 2021 and held it in 9 quarters. The position peaked at $30K in Q2 2021. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

Itau Unibanco Holding S.A. reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 898 Pacific Biosciences shares in Q1 2024, an estimated $8.81K.
Itau Unibanco Holding S.A. first reported a position in Pacific Biosciences in Q2 2021 and held it in 9 quarters.
Itau Unibanco Holding S.A.'s Pacific Biosciences position peaked at $30K in Q2 2021.
268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.